Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × HER-2 Negative Breast Cancer × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 NSCLC 2 Lymphoma, Non-Hodgkin 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Adenocarcinoma 2 Patient Acceptance of Health Care 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 Multiple Myeloma 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 HER-2 Negative Breast Cancer 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Acute Kidney Injury 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03799692 2019-01-10

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Fudan University

Phase 4 Unknown

HER-2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡